Bring on the biomarkers

George Poste

doi:10.1038/469156a

Bring on the biomarkers

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	156-157
Number of pages	2
Journal	Nature
Volume	469
Issue number	7329
DOIs	https://doi.org/10.1038/469156a
State	Published - Jan 13 2011

ASJC Scopus subject areas

General

Access to Document

10.1038/469156a

Cite this

@article{9f181500c2ce4271a01c1e752e4c6c46,

title = "Bring on the biomarkers",

author = "George Poste",

note = "Funding Information: Most important, funding agencies, such as the NIH, the European Framework Programme, the Innovative Medicines Initiative (also in Europe) and the UK Wellcome Trust, should demand better returns for their investments in biomarker research. They should support only research programmes that: have access to a sufficient number of stringently characterized specimens; impose rigorous quality control in specimen acquisition, handling and storage; and possess the full spectrum of cross-disciplinary capabilities needed to translate laboratory findings to the clinic. This would encourage academic laboratories to become part of larger research networks that include clinical and industrial partners.",

year = "2011",

month = jan,

day = "13",

doi = "10.1038/469156a",

language = "English (US)",

volume = "469",

pages = "156--157",

journal = "Nature",

issn = "0028-0836",

publisher = "Nature Publishing Group",

number = "7329",

}

TY - JOUR

T1 - Bring on the biomarkers

AU - Poste, George

N1 - Funding Information: Most important, funding agencies, such as the NIH, the European Framework Programme, the Innovative Medicines Initiative (also in Europe) and the UK Wellcome Trust, should demand better returns for their investments in biomarker research. They should support only research programmes that: have access to a sufficient number of stringently characterized specimens; impose rigorous quality control in specimen acquisition, handling and storage; and possess the full spectrum of cross-disciplinary capabilities needed to translate laboratory findings to the clinic. This would encourage academic laboratories to become part of larger research networks that include clinical and industrial partners.

PY - 2011/1/13

Y1 - 2011/1/13

UR - http://www.scopus.com/inward/record.url?scp=78651394465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651394465&partnerID=8YFLogxK

U2 - 10.1038/469156a

DO - 10.1038/469156a

M3 - Comment/debate

C2 - 21228852

AN - SCOPUS:78651394465

SN - 0028-0836

VL - 469

SP - 156

EP - 157

JO - Nature

JF - Nature

IS - 7329

ER -

Bring on the biomarkers

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this